Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| STAT5A | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 2.39E5 | Evidence |
O
|
||||
| STAT5A | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 1.37E5 | Evidence |
|
||||
| STAT5A | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 1.28E5 | Evidence | |||||
| STAT5A | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 1.18E5 | Evidence | |||||
| STAT5A | KIT | KIT: Mast/stem cell growth factor receptor precursor | 1.11E5 | Evidence |
|
||||
| STAT5A | CRKL | CRKL: Crk-like protein | 9.84E4 | Evidence |
O
|
||||
| STAT5A | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 9.37E4 | Evidence |
O
|
||||
| STAT5A | INSR | INSR: Insulin receptor precursor | 6.35E4 | Evidence |
|
||||
| STAT5A | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 5.72E4 | Evidence |
|
||||
| STAT5A | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 3.37E4 | Evidence | |||||
| STAT5A | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 3.01E4 | Evidence |
|
||||
| STAT5A | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 2.58E4 | Evidence |
|
||||
| STAT5A | CREBBP | CREBBP, CBP: CREB-binding protein | 1.07E4 | Evidence | |||||
| STAT5A | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 1.02E4 | Evidence |
|
||||
| STAT5A | GRAP | GRAP: GRB2-related adapter protein | 7.29E3 | Evidence | |||||
| STAT5A | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 6.59E3 | Evidence | |||||
| STAT5A | HDAC1 | HDAC1, RPD3L1: Histone deacetylase 1 | 6.01E3 | Evidence | |||||
| STAT5A | STAT3 | 2.89E3 | Evidence |
|
|||||
| STAT5A | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 2.27E3 | Evidence | |||||
| STAT5A | MAP2K3 | N/A | 1.67E3 | Evidence | |||||
| STAT5A | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 1.01E3 | Evidence | |||||
| STAT5A | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 835.0 | Evidence | |||||
| STAT5A | SHC4 | SHC-transforming protein 4 | 591.0 | Evidence | |||||
| STAT5A | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 555.0 | Evidence |
|
||||
| STAT5A | SYK | SYK: Tyrosine-protein kinase SYK | 497.0 | Evidence |
|
||||
| STAT5A | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 497.0 | Evidence |
|
||||
| STAT5A | HCK | N/A | 407.0 | Evidence | |||||
| STAT5A | LYN | LYN: Tyrosine-protein kinase Lyn | 407.0 | Evidence | |||||
| STAT5A | JAK1 | 407.0 | Evidence |
O
|
|||||
| STAT5A | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 407.0 | Evidence | |||||
| STAT5A | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 345.0 | Evidence | |||||
| STAT5A | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 325.0 | Evidence | |||||
| STAT5A | CSK | CSK: Tyrosine-protein kinase CSK | 301.0 | Evidence | |||||
| STAT5A | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 275.0 | Evidence |
|
||||
| STAT5A | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 268.0 | Evidence | |||||
| STAT5A | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 200.0 | Evidence |
|
||||
| STAT5A | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 200.0 | Evidence | |||||
| STAT5A | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 177.0 | Evidence |
|
||||
| STAT5A | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 158.0 | Evidence | |||||
| STAT5A | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 135.0 | Evidence | |||||
| STAT5A | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 135.0 | Evidence | |||||
| STAT5A | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 132.0 | Evidence |
|
||||
| STAT5A | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 132.0 | Evidence | |||||
| STAT5A | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 119.0 | Evidence | |||||
| STAT5A | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 119.0 | Evidence | |||||
| STAT5A | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 107.0 | Evidence | |||||
| STAT5A | BMX | N/A | 107.0 | Evidence |
|
||||
| STAT5A | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 106.0 | Evidence | |||||
| STAT5A | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 105.0 | Evidence | |||||
| STAT5A | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 104.0 | Evidence | |||||
| STAT5A | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 90.80 | Evidence | |||||
| STAT5A | FGFR4 | FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor | 90.80 | Evidence | |||||
| STAT5A | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 85.20 | Evidence | |||||
| STAT5A | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 85.20 | Evidence | |||||
| STAT5A | CD2AP | CD2AP: CD2-associated protein | 85.20 | Evidence | |||||
| STAT5A | DOK1 | DOK1: Docking protein 1 | 85.20 | Evidence | |||||
| STAT5A | VAV1 | VAV1, VAV: Proto-oncogene vav | 85.20 | Evidence | |||||
| STAT5A | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 81.20 | Evidence | |||||
| STAT5A | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 79.90 | Evidence | |||||
| STAT5A | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 70.10 | Evidence | |||||
| STAT5A | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 65.30 | Evidence | |||||
| STAT5A | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 62.90 | Evidence | |||||
| STAT5A | WASPIP | N/A | 62.90 | Evidence | |||||
| STAT5A | PTEN | PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du | 62.90 | Evidence | |||||
| STAT5A | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 62.90 | Evidence | |||||
| STAT5A | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 57.70 | Evidence | |||||
| STAT5A | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 51.60 | Evidence | |||||
| STAT5A | LCP1 | LCP1, PLS2: Plastin-2 | 51.60 | Evidence | |||||
| STAT5A | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 51.50 | Evidence | |||||
| STAT5A | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 51.50 | Evidence | |||||
| STAT5A | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 51.50 | Evidence | |||||
| STAT5A | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 51.50 | Evidence | |||||
| STAT5A | MET | MET: Hepatocyte growth factor receptor precursor | 47.20 | Evidence | |||||
| STAT5A | CXCR4 | CXCR4: C-X-C chemokine receptor type 4 | 46.30 | Evidence | |||||
| STAT5A | IL10RA | IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor | 46.30 | Evidence | |||||
| STAT5A | PPP2CB | PPP2CB: Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform | 44.20 | Evidence | |||||
| STAT5A | IRS2 | IRS2: Insulin receptor substrate 2 | 43.60 | Evidence | |||||
| STAT5A | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 43.60 | Evidence | |||||
| STAT5A | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 42.6 | Evidence | |||||
| STAT5A | STAM | STAM, STAM1: Signal transducing adapter molecule 1 | 39.10 | Evidence | |||||
| STAT5A | NCK2 | NCK2: Cytoplasmic protein NCK2 | 39.10 | Evidence | |||||
| STAT5A | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 38.10 | Evidence | |||||
| STAT5A | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 38.10 | Evidence | |||||
| STAT5A | CCR5 | CCR5: CCR5 receptor (Fragment) | 37.90 | Evidence |
|
||||
| STAT5A | HLA-DMB | HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec | 37.90 | Evidence | |||||
| STAT5A | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 37.90 | Evidence | |||||
| STAT5A | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 37.90 | Evidence | |||||
| STAT5A | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 37.80 | Evidence | |||||
| STAT5A | LNK | SH2B3, LNK: SH2B adapter protein 3 | 37.80 | Evidence | |||||
| STAT5A | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 37.80 | Evidence | |||||
| STAT5A | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 34.80 | Evidence | |||||
| STAT5A | MAP3K8 | MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 | 34.80 | Evidence | |||||
| STAT5A | SOS1 | SOS1: Son of sevenless homolog 1 | 33.90 | Evidence | |||||
| STAT5A | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 33.90 | Evidence | |||||
| STAT5A | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 33.90 | Evidence | |||||
| STAT5A | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 33.90 | Evidence | |||||
| STAT5A | ACTN4 | ACTN4: Alpha-actinin-4 | 33.90 | Evidence | |||||
| STAT5A | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 33.90 | Evidence | |||||
| STAT5A | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 33.90 | Evidence | |||||
| STAT5A | CDK2 | CDK2: Cell division protein kinase 2 | 32.80 | Evidence | |||||
| STAT5A | STYK1 | STYK1, NOK: Tyrosine protein-kinase STYK1 | 32.70 | Evidence | |||||
| STAT5A | PPP1R12A | PPP1R12A, MBS, MYPT1: Protein phosphatase 1 regulatory subunit 12A | 31.70 | Evidence | |||||
| STAT5A | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 31.20 | Evidence |
O
|
||||
| STAT5A | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 31.20 | Evidence | |||||
| STAT5A | CSNK1E | CSNK1E: Casein kinase I isoform epsilon | 31.20 | Evidence | |||||
| STAT5A | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 31.20 | Evidence | |||||
| STAT5A | ETS2 | ETS2: Protein C-ets-2 | 28.70 | Evidence | |||||
| STAT5A | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 28.70 | Evidence | |||||
| STAT5A | H1FX | H1FX: Histone H1x | 28.30 | Evidence | |||||
| STAT5A | GAB1 | GAB1: GRB2-associated-binding protein 1 | 28.20 | Evidence | |||||
| STAT5A | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 28.00 | Evidence | |||||
| STAT5A | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 27.90 | Evidence | |||||
| STAT5A | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 27.90 | Evidence | |||||
| STAT5A | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 26.80 | Evidence | |||||
| STAT5A | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 26.40 | Evidence | |||||
| STAT5A | MUSK | MUSK: Muscle, skeletal receptor tyrosine protein kinase precursor | 26.40 | Evidence | |||||
| STAT5A | MLH1 | MLH1, COCA2: DNA mismatch repair protein Mlh1 | 26.00 | Evidence | |||||
| STAT5A | NFKBIA | NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha | 26.00 | Evidence | |||||
| STAT5A | PPP2CA | PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | 26.00 | Evidence |
|
||||
| STAT5A | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 25.70 | Evidence |
|
||||
| STAT5A | BRD2 | BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 | 25.30 | Evidence | |||||
| STAT5A | SAFB | SAFB, HAP, HET, SAFB1: Scaffold attachment factor B | 25.30 | Evidence | |||||
| STAT5A | DAB1 | DAB1: Disabled homolog 1 | 25.3 | Evidence | |||||
| STAT5A | APS | SH2B2, APS: SH2B adapter protein 2 | 25.3 | Evidence | |||||
| STAT5A | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 25.3 | Evidence | |||||
| STAT5A | STAM2 | STAM2: Signal transducing adapter molecule 2 | 25.3 | Evidence | |||||
| STAT5A | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 24.90 | Evidence | |||||
| STAT5A | MDGA1 | MDGA1, MAMDC3: MAM domain-containing glycosylphosphatidylinositol anchor protein | 24.90 | Evidence | |||||
| STAT5A | CD79B | CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p | 24.90 | Evidence | |||||
| STAT5A | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 24.90 | Evidence |
|
||||
| STAT5A | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 24.90 | Evidence | |||||
| STAT5A | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 24.90 | Evidence | |||||
| STAT5A | CCR2 | CCR2, CMKBR2: C-C chemokine receptor type 2 | 24.90 | Evidence | |||||
| STAT5A | IL4R | IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor | 24.90 | Evidence | |||||
| STAT5A | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 24.80 | Evidence | |||||
| STAT5A | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 23.70 | Evidence | |||||
| STAT5A | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 23.70 | Evidence | |||||
| STAT5A | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 23.70 | Evidence | |||||
| STAT5A | EPOR | EPOR: Erythropoietin receptor precursor | 22.90 | Evidence |
|
||||
| STAT5A | GHR | GHR: Growth hormone receptor precursor | 22.90 | Evidence |
|
||||
| STAT5A | AMPH | AMPH, AMPH1: Amphiphysin | 22.90 | Evidence | |||||
| STAT5A | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 22.90 | Evidence | |||||
| STAT5A | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 22.90 | Evidence | |||||
| STAT5A | OSBPL11 | OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 | 22.80 | Evidence | |||||
| STAT5A | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 22.60 | Evidence | |||||
| STAT5A | IRS1 | IRS1: Insulin receptor substrate 1 | 22.40 | Evidence | |||||
| STAT5A | L1CAM | L1CAM, CAML1, MIC5: Neural cell adhesion molecule L1 precursor | 22.30 | Evidence | |||||
| STAT5A | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 22.30 | Evidence | |||||
| STAT5A | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 22.20 | Evidence | |||||
| STAT5A | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 22.20 | Evidence | |||||
| STAT5A | DYRK3 | N/A | 22.20 | Evidence | |||||
| STAT5A | TRADD | TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein | 21.40 | Evidence | |||||
| STAT5A | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 20.6 | Evidence | |||||
| STAT5A | TUBB | TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain | 20.6 | Evidence | |||||
| STAT5A | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 20.50 | Evidence | |||||
| STAT5A | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 20.50 | Evidence | |||||
| STAT5A | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 20.50 | Evidence | |||||
| STAT5A | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 20.50 | Evidence | |||||
| STAT5A | LATS2 | LATS2, KPM: Serine/threonine-protein kinase LATS2 | 20.50 | Evidence | |||||
| STAT5A | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 20.50 | Evidence | |||||
| STAT5A | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 20.50 | Evidence | |||||
| STAT5A | BIN1 | BIN1, AMPHL: Myc box-dependent-interacting protein 1 | 20.50 | Evidence | |||||
| STAT5A | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 20.10 | Evidence | |||||
| STAT5A | MYO3A | MYO3A: Myosin IIIA | 20.00 | Evidence | |||||
| STAT5A | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 20.00 | Evidence | |||||
| STAT5A | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 19.20 | Evidence | |||||
| STAT5A | NMI | NMI: N-myc-interactor | 19.00 | Evidence |
O
|
||||
| STAT5A | CDK5 | CDK5: Cell division protein kinase 5 | 18.90 | Evidence | |||||
| STAT5A | IFNAR1 | IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor | 18.60 | Evidence | |||||
| STAT5A | IL12RB2 | IL12RB2: Interleukin-12 receptor beta-2 chain precursor | 18.60 | Evidence | |||||
| STAT5A | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 18.60 | Evidence |
O
|
||||
| STAT5A | MPL | MPL, TPOR: Thrombopoietin receptor precursor | 18.60 | Evidence | |||||
| STAT5A | CD3E | CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor | 18.40 | Evidence | |||||
| STAT5A | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 17.60 | Evidence | |||||
| STAT5A | CDC2 | CDC2: Cell division control protein 2 homolog | 17.60 | Evidence | |||||
| STAT5A | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 17.50 | Evidence | |||||
| STAT5A | PRKR | EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki | 17.40 | Evidence | |||||
| STAT5A | LOC389305 | Uncharacterized protein ENSP00000349185 (Fragment) | 17.40 | Evidence | |||||
| STAT5A | TNFRSF1A | TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre | 17.10 | Evidence | |||||
| STAT5A | MAG | MAG, GMA: Myelin-associated glycoprotein precursor | 16.40 | Evidence | |||||
| STAT5A | CD1A | CD1A: T-cell surface glycoprotein CD1a precursor | 16.40 | Evidence | |||||
| STAT5A | EHD1 | EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 | 16.30 | Evidence | |||||
| STAT5A | HDAC3 | HDAC3: Histone deacetylase 3 | 15.30 | Evidence | |||||
| STAT5A | BARD1 | BARD1: BRCA1-associated RING domain protein 1 | 15.30 | Evidence | |||||
| STAT5A | CTDP1 | CTDP1, FCP1: RNA polymerase II subunit A C-terminal domain phosphatase | 15.30 | Evidence | |||||
| STAT5A | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 15.10 | Evidence | |||||
| STAT5A | VCAM1 | VCAM1, L1CAM: Vascular cell adhesion protein 1 precursor | 15.10 | Evidence | |||||
| STAT5A | PTPRR | PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor | 15.10 | Evidence | |||||
| STAT5A | ALCAM | ALCAM, MEMD: CD166 antigen precursor | 14.70 | Evidence | |||||
| STAT5A | PTPRJ | PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor | 14.70 | Evidence | |||||
| STAT5A | PRLR | PRLR: Prolactin receptor precursor | 14.70 | Evidence | |||||
| STAT5A | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 14.60 | Evidence |
|
||||
| STAT5A | RPS3 | RPS3, OK/SW-cl.26: 40S ribosomal protein S3 | 14.40 | Evidence | |||||
| STAT5A | PPIA | PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A | 14.40 | Evidence | |||||
| STAT5A | BCAN | BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor | 14.10 | Evidence | |||||
| STAT5A | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 13.90 | Evidence | |||||
| STAT5A | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 13.80 | Evidence | |||||
| STAT5A | CNKSR2 | CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 | 13.70 | Evidence | |||||
| STAT5A | CAMK2D | CAMK2D, CAMKD: Calcium/calmodulin-dependent protein kinase type II delta chain | 13.70 | Evidence | |||||
| STAT5A | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 13.70 | Evidence | |||||
| STAT5A | PTPRF | PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor | 13.50 | Evidence | |||||
| STAT5A | PHC2 | PHC2, EDR2, PH2: Polyhomeotic-like protein 2 | 13.50 | Evidence | |||||
| STAT5A | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 13.50 | Evidence | |||||
| STAT5A | DAB2 | DAB2, DOC2: Disabled homolog 2 | 13.50 | Evidence | |||||
| STAT5A | SORBS3 | SORBS3, SCAM1: Vinexin | 13.50 | Evidence | |||||
| STAT5A | MAP3K7 | MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 | 13.40 | Evidence | |||||
| STAT5A | CNTN2 | CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor | 13.20 | Evidence | |||||
| STAT5A | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 13.00 | Evidence | |||||
| STAT5A | MCM3 | MCM3: DNA replication licensing factor MCM3 | 12.50 | Evidence | |||||
| STAT5A | KLF13 | KLF13, BTEB3, NSLP1: Krueppel-like factor 13 | 12.40 | Evidence | |||||
| STAT5A | HSPB8 | HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 | 12.10 | Evidence | |||||
| STAT5A | CHUK | N/A | 11.80 | Evidence | |||||
| STAT5A | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 11.80 | Evidence | |||||
| STAT5A | CRK | CRK: Proto-oncogene C-crk | 11.70 | Evidence |
|
||||
| STAT5A | LOC649805 | Ig heavy chain V-II region COR | 11.70 | Evidence | |||||
| STAT5A | GRB10 | N/A | 11.70 | Evidence | |||||
| STAT5A | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 11.60 | Evidence | |||||
| STAT5A | HSP90AB1 | HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta | 11.50 | Evidence | |||||
| STAT5A | HDAC4 | HDAC4, KIAA0288: Histone deacetylase 4 | 11.30 | Evidence | |||||
| STAT5A | JUND | JUND: Transcription factor jun-D | 11.30 | Evidence | |||||
| STAT5A | OSTF1 | N/A | 11.30 | Evidence | |||||
| STAT5A | S100A3 | S100A3, S100E: Protein S100-A3 | 11.30 | Evidence | |||||
| STAT5A | CRIP2 | CRIP2, CRP2: Cysteine-rich protein 2 | 11.30 | Evidence | |||||
| STAT5A | S100B | S100B: Protein S100-B | 11.30 | Evidence | |||||
| STAT5A | PHB2 | PHB2, BAP, REA: Prohibitin-2 | 11.00 | Evidence | |||||
| STAT5A | PARVA | PARVA, MXRA2: Alpha-parvin | 10.80 | Evidence | |||||
| STAT5A | AP1GBP1 | AP1GBP1, SYNG: AP1 subunit gamma-binding protein 1 | 10.70 | Evidence | |||||
| STAT5A | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 10.60 | Evidence | |||||
| STAT5A | RP2 | RP2: Protein XRP2 | 10.60 | Evidence | |||||
| STAT5A | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 10.50 | Evidence | |||||
| STAT5A | SYNGAP1 | SYNGAP1, KIAA1938: Ras GTPase-activating protein SynGAP | 10.50 | Evidence | |||||
| STAT5A | INSRR | INSRR, IRR: Insulin receptor-related protein precursor | 10.50 | Evidence | |||||
| STAT5A | FADD | FADD, MORT1: Protein FADD | 10.30 | Evidence | |||||
| STAT5A | NR3C1 | NR3C1, GRL: Glucocorticoid receptor | 10.30 | Evidence |
|
||||
| STAT5A | EPRS | EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: | 10.30 | Evidence | |||||
| STAT5A | HSP90AA1 | Hsp89-alpha-delta-N | 10.30 | Evidence | |||||
| STAT5A | RPA2 | RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit | 10.30 | Evidence | |||||
| STAT5A | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 10.30 | Evidence | |||||
| STAT5A | FLNB | FLNB, FLN1L, FLN3, TABP, TAP: Filamin-B | 10.00 | Evidence | |||||
| STAT5A | CEACAM1 | CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr | 9.94 | Evidence | |||||
| STAT5A | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 9.92 | Evidence | |||||
| STAT5A | MAPK7 | mitogen-activated protein kinase 7 isoform 1 | 9.73 | Evidence | |||||
| STAT5A | FKBP1A | FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A | 9.55 | Evidence | |||||
| STAT5A | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 9.33 | Evidence | |||||
| STAT5A | RELA | RELA, NFKB3: Transcription factor p65 | 9.29 | Evidence | |||||
| STAT5A | FOS | FOS, G0S7: Proto-oncogene protein c-fos | 9.29 | Evidence | |||||
| STAT5A | BRCA1 | BRCA1, RNF53: Breast cancer type 1 susceptibility protein | 9.29 | Evidence |
O
|
||||
| STAT5A | NCF2 | NCF2: Neutrophil cytosol factor 2 | 9.29 | Evidence | |||||
| STAT5A | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 8.96 | Evidence | |||||
| STAT5A | IL10RB | IL10RB, CRFB4, D21S58, D21S66: Interleukin-10 receptor beta chain precursor | 8.92 | Evidence | |||||
| STAT5A | TIAM1 | TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 | 8.90 | Evidence | |||||
| STAT5A | S100A9 | S100A9, CAGB, CFAG, MRP14: Protein S100-A9 | 8.76 | Evidence | |||||
| STAT5A | KPNB1 | KPNB1, NTF97: Importin subunit beta-1 | 8.74 | Evidence | |||||
| STAT5A | VCP | VCP: Transitional endoplasmic reticulum ATPase | 8.72 | Evidence | |||||
| STAT5A | EVL | N/A | 8.72 | Evidence | |||||
| STAT5A | PTPN11 | N/A | 8.72 | Evidence |
|
||||
| STAT5A | PPP2R5A | PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha | 8.72 | Evidence | |||||
| STAT5A | AGTPBP1 | AGTPBP1, RP11-30C23.1-005, hCG_1743691: AGTPBP1 protein | 8.72 | Evidence | |||||
| STAT5A | CD44 | N/A | 8.44 | Evidence | |||||
| STAT5A | PRMT5 | PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 | 8.35 | Evidence | |||||
| STAT5A | MYL4 | MYL4, MLC1, PRO1957: Myosin light polypeptide 4 | 8.00 | Evidence | |||||
| STAT5A | TP53 | TP53, P53: Cellular tumor antigen p53 | 8.00 | Evidence | |||||
| STAT5A | ROCK2 | ROCK2, KIAA0619: Rho-associated protein kinase 2 | 7.99 | Evidence | |||||
| STAT5A | PAK7 | PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 | 7.99 | Evidence | |||||
| STAT5A | FABP4 | FABP4: Fatty acid-binding protein, adipocyte | 7.73 | Evidence | |||||
| STAT5A | MAL2 | MAL2: Protein MAL2 | 7.72 | Evidence | |||||
| STAT5A | HDAC2 | HDAC2: Histone deacetylase 2 | 7.45 | Evidence | |||||
| STAT5A | AGTR1 | AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor | 7.40 | Evidence | |||||
| STAT5A | KCNJ3 | KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 | 7.40 | Evidence | |||||
| STAT5A | UNG | N/A | 7.38 | Evidence | |||||
| STAT5A | ANP32B | ANP32B, APRIL, PHAPI2: Acidic leucine-rich nuclear phosphoprotein 32 family memb | 7.38 | Evidence | |||||
| STAT5A | PAPOLA | PAPOLA, PAP: Poly(A) polymerase alpha | 7.38 | Evidence | |||||
| STAT5A | MAP3K9 | MAP3K9, MLK1, PRKE1: Mitogen-activated protein kinase kinase kinase 9 | 7.14 | Evidence | |||||
| STAT5A | PTPRA | N/A | 7.14 | Evidence | |||||
| STAT5A | MARK2 | N/A | 7.14 | Evidence | |||||
| STAT5A | ADRB2 | ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor | 7.05 | Evidence | |||||
| STAT5A | JUN | JUN: Transcription factor AP-1 | 7.05 | Evidence | |||||
| STAT5A | CEBPB | CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta | 7.05 | Evidence |
O
|
||||
| STAT5A | CTLA4 | CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor | 6.98 | Evidence |
|
||||
| STAT5A | FOXM1 | FOXM1, FKHL16, HFH11, MPP2, WIN: Forkhead box protein M1 | 6.82 | Evidence | |||||
| STAT5A | EDNRB | EDNRB, ETRB: Endothelin B receptor precursor | 6.82 | Evidence | |||||
| STAT5A | STAT4 | STAT4: Signal transducer and activator of transcription 4 | 6.65 | Evidence | |||||
| STAT5A | TSHR | N/A | 6.63 | Evidence | |||||
| STAT5A | AKR7A2 | AKR7A2, AFAR, AFAR1, AKR7: Aflatoxin B1 aldehyde reductase member 2 | 6.62 | Evidence | |||||
| STAT5A | SOS2 | SOS2: Son of sevenless homolog 2 | 6.54 | Evidence | |||||
| STAT5A | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 6.45 | Evidence | |||||
| STAT5A | SIVA | SIVA1, SIVA: Apoptosis regulatory protein Siva | 6.40 | Evidence | |||||
| STAT5A | STAP2 | Uncharacterized protein ENSP00000317912 | 6.40 | Evidence |
|
||||
| STAT5A | MAP4K5 | MAP4K5: Mitogen-activated protein kinase kinase kinase kinase 5 | 6.31 | Evidence | |||||
| STAT5A | PRKCH | PRKCH, PKCL, PRKCL: Protein kinase C eta type | 6.31 | Evidence | |||||
| STAT5A | SOCS2 | SOCS2, CIS2, SSI2, STATI2: Suppressor of cytokine signaling 2 | 6.31 | Evidence | |||||
| STAT5A | IL6R | IL6R: Interleukin-6 receptor alpha chain precursor | 6.26 | Evidence | |||||
| STAT5A | ATP1A1 | ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor | 6.11 | Evidence | |||||
| STAT5A | PLEKHA4 | PLEKHA4, PEPP1: Pleckstrin homology domain-containing family A member 4 | 6.11 | Evidence | |||||
| STAT5A | RASGRF2 | RASGRF2: Ras protein-specific guanine nucleotide-releasing factor 2 (Fragment) | 6.11 | Evidence | |||||
| STAT5A | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 6.11 | Evidence | |||||
| STAT5A | BRDG1 | STAP1, BRDG1: Signal-transducing adaptor protein 1 | 6.11 | Evidence | |||||
| STAT5A | HPCAL1 | HPCAL1, BDR1: Hippocalcin-like protein 1 | 5.99 | Evidence | |||||
| STAT5A | HES1 | HES1, HL, HRY: Transcription factor HES-1 | 5.97 | Evidence | |||||
| STAT5A | KCNJ12 | KCNJ12, IRK2, KCNJN1: ATP-sensitive inward rectifier potassium channel 12 | 5.97 | Evidence | |||||
| STAT5A | HSPA8 | HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein | 5.73 | Evidence | |||||
| STAT5A | BCR | N/A | 5.73 | Evidence | |||||
| STAT5A | IGFBP5 | IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor | 5.66 | Evidence | |||||
| STAT5A | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 5.63 | Evidence | |||||
| STAT5A | THBS3 | THBS3, TSP3: Thrombospondin-3 precursor | 5.62 | Evidence | |||||
| STAT5A | IFNGR2 | IFNGT1, IFNGR2: Interferon-gamma receptor beta chain precursor | 5.54 | Evidence | |||||
| STAT5A | KPNA5 | KPNA5: Importin subunit alpha-6 | 5.46 | Evidence | |||||
| STAT5A | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 5.45 | Evidence | |||||
| STAT5A | TNNC1 | TNNC1, TNNC: Troponin C, slow skeletal and cardiac muscles | 5.41 | Evidence | |||||
| STAT5A | IRF1 | IRF1: Interferon regulatory factor 1 | 5.40 | Evidence | |||||
| STAT5A | FGFR2 | N/A | 5.34 | Evidence | |||||
| STAT5A | COPA | COPA: Coatomer subunit alpha | 5.28 | Evidence | |||||
| STAT5A | TNC | TNC, HXB: Tenascin precursor | 5.27 | Evidence | |||||
| STAT5A | PPARA | PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha | 5.11 | Evidence | |||||
| STAT5A | VAV3 | VAV3: Protein vav-3 | 5.04 | Evidence | |||||
| STAT5A | GNB2L1 | Lung cancer oncogene 7 | 4.99 | Evidence | |||||
| STAT5A | TOP2B | N/A | 4.99 | Evidence | |||||
| STAT5A | CALM2 | CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca | 4.85 | Evidence | |||||
| STAT5A | TRPV3 | TRPV3: Transient receptor potential cation channel subfamily V member 3 | 4.80 | Evidence | |||||
| STAT5A | CD200R1 | CD200R1, CD200R, CRTR2, MOX2R, OX2R: Cell surface glycoprotein OX2 receptor prec | 4.80 | Evidence | |||||
| STAT5A | KIR2DL3 | KIR2DL3, CD158B2, KIRCL23, NKAT2: Killer cell immunoglobulin-like receptor 2DL3 | 4.80 | Evidence | |||||
| STAT5A | C20orf75 | C20orf75: Uncharacterized protein C20orf75 precursor | 4.80 | Evidence | |||||
| STAT5A | FRS2 | FRS2: Fibroblast growth factor receptor substrate 2 | 4.77 | Evidence | |||||
| STAT5A | RAC2 | RAC2: Ras-related C3 botulinum toxin substrate 2 precursor | 4.58 | Evidence | |||||
| STAT5A | NR4A2 | NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 | 4.58 | Evidence | |||||
| STAT5A | VDR | VDR, NR1I1: Vitamin D3 receptor | 4.58 | Evidence | |||||
| STAT5A | TRHR | TRHR: Thyrotropin-releasing hormone receptor | 4.56 | Evidence | |||||
| STAT5A | COPE | COPE: Coatomer subunit epsilon | 4.55 | Evidence | |||||
| STAT5A | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 4.51 | Evidence | |||||
| STAT5A | EP300 | N/A | 4.47 | Evidence |
|
||||
| STAT5A | NUP153 | N/A | 4.47 | Evidence | |||||
| STAT5A | IRF2 | IRF2: Interferon regulatory factor 2 | 4.42 | Evidence | |||||
| STAT5A | RNF31 | ISGF3G, IRF9: Transcriptional regulator ISGF3 subunit gamma | 4.42 | Evidence | |||||
| STAT5A | IL3RA | IL3RA, IL3R: Interleukin-3 receptor alpha chain precursor | 4.42 | Evidence | |||||
| STAT5A | SNCG | SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein | 4.30 | Evidence | |||||
| STAT5A | SHC1 | SHC1, RP11-307C12.1-001, hCG_1997126: SHC | 4.28 | Evidence |
|
||||
| STAT5A | CRK | N/A | 4.28 | Evidence |
|
||||
| STAT5A | SOCS1 | SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 | 4.08 | Evidence | |||||
| STAT5A | GRB14 | GRB14: Growth factor receptor-bound protein 14 | 4.07 | Evidence | |||||
| STAT5A | CHGB | CHGB, SCG1: Secretogranin-1 precursor | 4.04 | Evidence | |||||
| STAT5A | NGFR | NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor | 4.04 | Evidence | |||||
| STAT5A | ELK1 | ELK1: ETS domain-containing protein Elk-1 | 4.02 | Evidence | |||||
| STAT5A | STMN1 | STMN1, LAP18, OP18: Stathmin | 4.01 | Evidence | |||||
| STAT5A | SUPT5H | SUPT5H, SPT5, SPT5H: Transcription elongation factor SPT5 | 4.00 | Evidence | |||||
| STAT5A | CASP9 | CASP9, MCH6: Caspase-9 precursor | 3.88 | Evidence | |||||
| STAT5A | PTPN7 | N/A | 3.88 | Evidence | |||||
| STAT5A | DAPP1 | N/A | 3.87 | Evidence | |||||
| STAT5A | GMFB | GMFB: Glia maturation factor beta | 3.77 | Evidence | |||||
| STAT5A | VIL1 | VIL1, VIL: Villin-1 | 3.77 | Evidence | |||||
| STAT5A | OSBPL6 | OSBPL6, ORP6: Oxysterol-binding protein-related protein 6 | 3.70 | Evidence | |||||
| STAT5A | DUSP10 | DUSP10, MKP5: Dual specificity protein phosphatase 10 | 3.70 | Evidence | |||||
| STAT5A | SCARB2 | SCARB2, CD36L2, LIMPII: Lysosome membrane protein 2 | 3.62 | Evidence | |||||
| STAT5A | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 3.62 | Evidence | |||||
| STAT5A | SOCS5 | SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 | 3.62 | Evidence | |||||
| STAT5A | PIAS1 | PIAS1, DDXBP1: E3 SUMO-protein ligase PIAS1 | 3.58 | Evidence | |||||
| STAT5A | KPNA6 | N/A | 3.52 | Evidence | |||||
| STAT5A | DUSP2 | DUSP2, PAC1: Dual specificity protein phosphatase 2 | 3.41 | Evidence | |||||
| STAT5A | POLR2A | POLR2A: Uncharacterized protein POLR2A | 3.39 | Evidence | |||||
| STAT5A | ITGAV | ITGAV, MSK8, VNRA: Integrin alpha-V precursor | 3.31 | Evidence | |||||
| STAT5A | ITGA2B | ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor | 3.30 | Evidence | |||||
| STAT5A | OPTC | OPTC, OPT: Opticin precursor | 3.28 | Evidence | |||||
| STAT5A | PCDHA2 | PCDHA2: Protocadherin alpha 2 precursor | 3.28 | Evidence | |||||
| STAT5A | CHN2 | CHN2, ARHGAP3, BCH: Beta-chimaerin | 3.24 | Evidence | |||||
| STAT5A | POU2F1 | POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 | 3.02 | Evidence |
|
||||
| STAT5A | BUB3 | BUB3: Mitotic checkpoint protein BUB3 | 2.93 | Evidence | |||||
| STAT5A | NUP98 | N/A | 2.93 | Evidence | |||||
| STAT5A | HNRPM | HNRPM, NAGR1: Heterogeneous nuclear ribonucleoprotein M | 2.93 | Evidence | |||||
| STAT5A | SCN4B | SCN4B: Sodium channel beta-4 subunit precursor | 2.91 | Evidence | |||||
| STAT5A | HLA-DQA1 | HLA-DQA2, HLA-DXA: HLA class II histocompatibility antigen, DQ(6) alpha chain pr | 2.91 | Evidence | |||||
| STAT5A | CRLF2 | CRLF2, ILXR, TSLPR: Cytokine receptor-like factor 2 precursor | 2.91 | Evidence | |||||
| STAT5A | BTLA | BTLA: B- and T-lymphocyte attenuator precursor | 2.91 | Evidence | |||||
| STAT5A | ESR1 | ESR1, ESR, NR3A1: Estrogen receptor | 2.83 | Evidence |
|
||||
| STAT5A | TCF3 | TCF3, E2A, ITF1: Transcription factor E2-alpha | 2.70 | Evidence | |||||
| STAT5A | GGCX | GGCX, GC: Vitamin K-dependent gamma-carboxylase | 2.70 | Evidence | |||||
| STAT5A | SHC2 | N/A | 2.69 | Evidence | |||||
| STAT5A | CAV1 | CAV1, CAV: Caveolin-1 | 2.66 | Evidence | |||||
| STAT5A | PEA15 | PEA15: Astrocytic phosphoprotein PEA-15 | 2.59 | Evidence | |||||
| STAT5A | HPCA | HPCA, BDR2: Neuron-specific calcium-binding protein hippocalcin | 2.53 | Evidence | |||||
| STAT5A | VEPH1 | VEPH1, KIAA1692, VEPH: Ventricular zone-expressed PH domain-containing protein h | 2.43 | Evidence | |||||
| STAT5A | ASB2 | ASB2: Ankyrin repeat and SOCS box protein 2 | 2.43 | Evidence | |||||
| STAT5A | RAC1 | N/A | 2.28 | Evidence | |||||
| STAT5A | KCNAB2 | KCNAB2, KCNA2B, KCNK2: Voltage-gated potassium channel subunit beta-2 | 2.28 | Evidence | |||||
| STAT5A | LOC392481 | N/A | 2.23 | Evidence | |||||
| STAT5A | PIAS4 | PIAS4, PIASG: E3 SUMO-protein ligase PIAS4 | 2.22 | Evidence | |||||
| STAT5A | SHB | SHB: SH2 domain-containing adapter protein B | 2.21 | Evidence | |||||
| STAT5A | ASGR1 | ASGR1: Asialoglycoprotein receptor 1 | 2.19 | Evidence | |||||
| STAT5A | ITGB3 | ITGB3, GP3A: Integrin beta-3 precursor | 2.19 | Evidence | |||||
| STAT5A | ST14 | ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 | 2.19 | Evidence | |||||
| STAT5A | STMN2 | STMN2, SCG10, SCGN10: Stathmin-2 | 2.06 | Evidence | |||||
| STAT5A | HIF1A | HIF1A, MOP1: Hypoxia-inducible factor 1 alpha | 2.05 | Evidence | |||||
| STAT5A | FSHR | FSHR, LGR1: Follicle-stimulating hormone receptor precursor | 2.05 | Evidence | |||||
| STAT5A | SNAP25 | N/A | 1.98 | Evidence | |||||
| STAT5A | RAB4A | N/A | 1.98 | Evidence | |||||
| STAT5A | RAVER1 | RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 | 1.98 | Evidence | |||||
| STAT5A | NFIA | NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A | 1.98 | Evidence | |||||
| STAT5A | ZCCHC3 | ZCCHC3, C20orf99: Zinc finger CCHC domain-containing protein 3 | 1.98 | Evidence | |||||
| STAT5A | TNFSF13B | TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto | 1.98 | Evidence | |||||
| STAT5A | CSF3R | N/A | 1.98 | Evidence | |||||
| STAT5A | GABRB1 | GABRB1: Gamma-aminobutyric acid receptor subunit beta-1 precursor | 1.96 | Evidence | |||||
| STAT5A | APP | APP, A4, AD1: Amyloid beta A4 protein precursor | 1.78 | Evidence | |||||
| STAT5A | TAL2 | TAL2: T-cell acute lymphocytic leukemia protein 2 | 1.78 | Evidence | |||||
| STAT5A | COPB2 | COPB2: Coatomer subunit beta' | 1.76 | Evidence | |||||
| STAT5A | RPL7 | RPL7: 60S ribosomal protein L7 | 1.75 | Evidence | |||||
| STAT5A | PDCD1 | PDCD1, PD1: Programmed cell death protein 1 precursor | 1.72 | Evidence | |||||
| STAT5A | LRFN3 | LRFN3, UNQ5865/PRO34192: Leucine-rich repeat and fibronectin type-III domain-con | 1.72 | Evidence | |||||
| STAT5A | DUSP4 | DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 | 1.71 | Evidence | |||||
| STAT5A | PPFIA1 | PPFIA1, LIP1: Liprin-alpha-1 | 1.71 | Evidence | |||||
| STAT5A | TAL1 | TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 | 1.64 | Evidence | |||||
| STAT5A | PLEKHA1 | PLEKHA1, TAPP1: Pleckstrin homology domain-containing family A member 1 | 1.59 | Evidence | |||||
| STAT5A | TGFB1 | TGFB1, TGFB: Transforming growth factor beta-1 precursor | 1.45 | Evidence | |||||
| STAT5A | RELB | RELB: Transcription factor RelB | 1.43 | Evidence | |||||
| STAT5A | WWC2 | WW and C2 domain containing 2 | 1.35 | Evidence | |||||
| STAT5A | P4HB | P4HB, ERBA2L, PDI, PDIA1, PO4DB: Protein disulfide-isomerase precursor | 1.31 | Evidence | |||||
| STAT5A | LHCGR | LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor | 1.26 | Evidence | |||||
| STAT5A | SELE | SELE, ELAM1: E-selectin precursor | 1.17 | Evidence | |||||
| STAT5A | NKX2-5 | NKX2-5, CSX, NKX2.5, NKX2E: Homeobox protein Nkx-2.5 | 1.17 | Evidence | |||||
| STAT5A | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 1.17 | Evidence | |||||
| STAT5A | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 1.15 | Evidence | |||||
| STAT5A | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 1.13 | Evidence | |||||
| STAT5A | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 1.13 | Evidence | |||||
| STAT5A | RPL19 | RPL19: 60S ribosomal protein L19 | 1.11 | Evidence | |||||
| STAT5A | FLJ16636 | ZNF782: Zinc finger protein 782 | 1.07 | Evidence | |||||
| STAT5A | PPFIA3 | PPFIA3, KIAA0654: Liprin-alpha-3 | 1.01 | Evidence | |||||